Jonas Koch
Overview
Explore the profile of Jonas Koch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu J, Koch J, Schmidt C, Nientiedt M, Neuberger M, Erben P, et al.
Exp Mol Med
. 2024 Dec;
57(1):118-130.
PMID: 39741187
Bladder cancer poses significant clinical challenges due to its high metastatic potential and poor prognosis, especially when it progresses to muscle-invasive stages. Here, we show that the mA reader YTHDC1...
2.
Koch J, Lyko F
Curr Opin Genet Dev
. 2024 Aug;
88:102242.
PMID: 39111230
N-methyladenosine (mA) is the most abundant internal modification of eukaryotic mRNAs. mA affects the fate of its targets in all aspects of the mRNA life cycle and has important roles...
3.
Matschiner E, Serban O, Fodor D, Blaivas M, Horn R, Koch J, et al.
Med Ultrason
. 2024 Jul;
27(1):52-62.
PMID: 39078997
Aim: This meta-analysis evaluates the diagnostic accuracy of ultrasound (US) for bone fractures over the past 47 years, comparing it to established imaging standards. Material And Methods: We adhered to...
4.
Lucius C, Nielsen M, Blaivas M, Burmester E, Westerway S, Chu C, et al.
Endosc Ultrasound
. 2023 Sep;
12(3):311-318.
PMID: 37693111
Simulation has been shown to improve clinical learning outcomes, speed up the learning process, and improve trainee confidence, while taking the pressure off initial face-to-face patient clinical areas. The second...
5.
Koch J, Neuberger M, Schmidt-Dengler M, Xu J, Carneiro V, Ellinger J, et al.
iScience
. 2023 Aug;
26(8):107300.
PMID: 37554463
METTL3 is the major writer of N6-Methyladenosine (mA) and has been associated with controversial roles in cancer. This is best illustrated in urothelial carcinoma of the bladder (UCB), where METTL3...
6.
Koch J, Scheps D, Gunne M, Boscheinen O, Frech C
J Chromatogr B Analyt Technol Biomed Life Sci
. 2023 May;
1224:123735.
PMID: 37182410
In this work, the effect of the salt modulators potassium chloride, ammonium chloride, ammonium sulfate, and potassium sulfate on the elution behavior of insulin in reversed-phase chromatography with ethanol as...
7.
Lorvellec M, Chouquet A, Koch J, Bally I, Signor L, Vigne J, et al.
Front Immunol
. 2023 May;
14:1151731.
PMID: 37180096
Complement C1s association with the pathogenesis of several diseases cannot be simply explained only by considering its main role in activating the classical complement pathway. This suggests that non-canonical functions...
8.
Koch J, Scheps D, Gunne M, Boscheinen O, Frech C
J Sep Sci
. 2023 Feb;
46(9):e2300031.
PMID: 36846902
In process development and characterization, the scale-up of chromatographic steps is a crucial part and brings a number of challenges. Usually, scale-down models are used to represent the process step,...
9.
Dietrich C, Lucius C, Nielsen M, Burmester E, Westerway S, Chu C, et al.
Endosc Ultrasound
. 2023 Jan;
12(1):38-49.
PMID: 36629173
Simulation has been shown to improve clinical learning outcomes, speed up the learning process and improve learner confidence, whilst initially taking pressure off busy clinical lists. The World Federation for...
10.
Dong Y, Koch J, Alhyari A, Safai Zadeh E, Gorg C, Wang W, et al.
Z Gastroenterol
. 2022 Dec;
61(4):399-410.
PMID: 36516951
Focal liver lesions (FLL) are typically detected by conventional ultrasound or other imaging modalities. After the detection of FLL, further characterization is essential, and this can be done by contrast-enhanced...